PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Pulmonary Aspergillosis D055732 1 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Cryptorchidism D003456 2 associated lipids
Decapitation D049248 2 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kaur S et al. Induction of prostaglandin D2 through the p38 MAPK pathway is responsible for the antipruritic activity of sertaconazole nitrate. 2010 J. Invest. Dermatol. pmid:20505747
Kuwamoto K et al. Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice. 2000 J. Invest. Dermatol. pmid:10651981
Roberts LJ and Oates JA Biochemical diagnosis of systemic mast cell disorders. 1991 J. Invest. Dermatol. pmid:16799604
Ikai K et al. Induction of 72-kD heat shock protein and cytoskeleton damage by cytotoxic prostaglandin delta 12-PGJ2 in transformed human epidermal cells in culture. 1992 J. Invest. Dermatol. pmid:1375619
de Paulis A et al. Anti-inflammatory effect of FK-506 on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1281861
Hawk JL et al. Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. 1983 J. Invest. Dermatol. pmid:6343514
Mössner R et al. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. 2002 J. Invest. Dermatol. pmid:12230498
Iwasaki M et al. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. 2002 J. Invest. Dermatol. pmid:12230502
Ikai K et al. Effect of ultraviolet irradiation on mast cell-deficient W/Wv mice. 1985 J. Invest. Dermatol. pmid:3859552
Ruzicka T et al. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. 1986 J. Invest. Dermatol. pmid:3018086
Bull HA et al. Basophil mediator release in atopic dermatitis. 1993 J. Invest. Dermatol. pmid:7680056
Krishnaswamy G et al. Regulation of eosinophil-active cytokine production from human cord blood-derived mast cells. 2002 J. Interferon Cytokine Res. pmid:12034046
Sichletidis L et al. Comparative efficacy of salbutamol and salmeterol in exercise-induced asthma. 1993 Mar-Apr J. Int. Med. Res. pmid:8243793
Cloutier A et al. The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. 2012 J. Infect. Dis. pmid:22219346
Nitta N et al. Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device -- TAXIScan. 2007 J. Immunol. Methods pmid:17289072
Andersen HB et al. Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells. 2008 J. Immunol. Methods pmid:18538784
Kawata R et al. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. 1995 J. Immunol. pmid:7608559
Schleimer RP et al. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. 1986 J. Immunol. pmid:3082976
Marx N et al. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. 2000 J. Immunol. pmid:10843708
Nencioni A et al. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. 2003 J. Immunol. pmid:14607914
Ruzicka T and Auböck J Arachidonic acid metabolism in guinea pig Langerhans cells: studies on cyclooxygenase and lipoxygenase pathways. 1987 J. Immunol. pmid:3098849
Spik I et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. 2005 J. Immunol. pmid:15749909
Fujitani Y et al. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. 2002 J. Immunol. pmid:11751991
Chen CW et al. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. 2003 J. Immunol. pmid:12847270
Clark RB et al. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. 2000 J. Immunol. pmid:10640751
Reilly CM et al. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. 2000 J. Immunol. pmid:10640767
Hirai H et al. Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. 2002 J. Immunol. pmid:11801628
Harris SG et al. 15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. 2002 J. Immunol. pmid:11801678
Diaz BL et al. Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids. 2002 J. Immunol. pmid:11801681
Vaidya S et al. 15-Deoxy-Delta12,1412,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation. 1999 J. Immunol. pmid:10570310
Patella V et al. Eosinophil granule proteins activate human heart mast cells. 1996 J. Immunol. pmid:8757629
Murakami M et al. Cyclooxygenase-2-dependent delayed prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: its augmentation by extracellular type II secretory phospholipase A2. 1997 J. Immunol. pmid:9200484
Maier NK et al. The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes. 2015 J. Immunol. pmid:25681332
Broide DH et al. Functional and biochemical characterization of rat bone marrow derived mast cells. 1988 J. Immunol. pmid:2974057
Katz HR et al. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. 1992 J. Immunol. pmid:1309842
Serghides L and Kain KC Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. 2001 J. Immunol. pmid:11359831
Tsubosaka Y et al. A deficiency in the prostaglandin D2 receptor CRTH2 exacerbates adjuvant-induced joint inflammation. 2014 J. Immunol. pmid:25362177
Lee KH et al. Stimulatory function of gp49A, a murine Ig-like receptor, in rat basophilic leukemia cells. 2000 J. Immunol. pmid:11046024
Enomoto A et al. Redundant and segregated functions of granule-associated heparin-binding group II subfamily of secretory phospholipases A2 in the regulation of degranulation and prostaglandin D2 synthesis in mast cells. 2000 J. Immunol. pmid:11034411
Padilla J et al. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. 2000 J. Immunol. pmid:11120820
Raible DG et al. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. 1992 J. Immunol. pmid:1588043
Hortelano S et al. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. 2000 J. Immunol. pmid:11086094
Hellmann J et al. Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production. 2013 J. Immunol. pmid:23785121
Levi-Schaffer F et al. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. 1987 J. Immunol. pmid:2445814
Zhang X et al. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. 2001 J. Immunol. pmid:11390455
Angeli V et al. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. 2004 J. Immunol. pmid:15004188
Heavey DJ et al. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells. 1988 J. Immunol. pmid:2450136
Wells E et al. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. 1986 J. Immunol. pmid:2431049
Parsons WG and Roberts LJ Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. 1988 J. Immunol. pmid:3139758
Nencioni A et al. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. 2002 J. Immunol. pmid:12133943
Rossi AG et al. Regulation of macrophage phagocytosis of apoptotic cells by cAMP. 1998 J. Immunol. pmid:9531319
Columbo M et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. 1992 J. Immunol. pmid:1378071
Sarashina H et al. Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation. 2014 J. Immunol. pmid:24298012
Kobayashi Y et al. Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation. 2005 J. Immunol. pmid:16237065
Bureau F et al. A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition. 2002 J. Immunol. pmid:11994490
Levi-Schaffer F et al. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. 1985 J. Immunol. pmid:2413121
Janabi N Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages. 2002 J. Immunol. pmid:11971025
Lewis RA et al. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. 1982 J. Immunol. pmid:6809826
Sturm EM et al. Opposing roles of prostaglandin D2 receptors in ulcerative colitis. 2014 J. Immunol. pmid:24929001
Steinke JW et al. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. 2014 J. Immunol. pmid:24890720
Giri S et al. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. 2004 J. Immunol. pmid:15470065
Lawrence ID et al. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. 1987 J. Immunol. pmid:2444649
Ward C et al. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. 2002 J. Immunol. pmid:12055237
Zhao W et al. TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathway. 2008 J. Immunol. pmid:18981148
Fionda C et al. 15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors. 2007 J. Immunol. pmid:17371958
Schick B et al. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1984 J. Immunol. pmid:6425408
Tada K et al. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions. 1998 J. Immunol. pmid:9794438
Urade Y et al. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. 1989 J. Immunol. pmid:2509561
Xue L et al. Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2. 2012 J. Immunol. pmid:22174450
Yoon HJ et al. Regulation of TLR2 expression by prostaglandins in brain glia. 2008 J. Immunol. pmid:18523308
Bissonnette SL et al. An endogenous prostaglandin enhances environmental phthalate-induced apoptosis in bone marrow B cells: activation of distinct but overlapping pathways. 2008 J. Immunol. pmid:18641309
Patella V et al. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. 1995 J. Immunol. pmid:7533185
Leal-Berumen I et al. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. 1995 J. Immunol. pmid:7536779
Cheron A et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. 2004 J. Immunol. pmid:15187150
Zingarelli B et al. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. 2003 J. Immunol. pmid:14662889
Colville-Nash PR et al. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. 1998 J. Immunol. pmid:9670978
Kuehn HS et al. The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells. 2008 J. Immunol. pmid:19017959
Rocklin RE et al. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2). 1985 J. Immunol. pmid:3160784
White MV et al. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE. 1991 J. Immunol. pmid:1712816
Lee JH et al. The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1. 2008 J. Immunol. pmid:19050284
Joo M et al. Induction and function of lipocalin prostaglandin D synthase in host immunity. 2007 J. Immunol. pmid:17675519
Mizutani N et al. Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. 2007 J. Immunol. pmid:18025192
Hammad H et al. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. 2003 J. Immunol. pmid:14530310
Xue L et al. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway. 2009 J. Immunol. pmid:19494281
Cippitelli M et al. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms. 2003 J. Immunol. pmid:12707336
Heinemann A et al. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. 2003 J. Immunol. pmid:12707356
Torres D et al. Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. 2008 J. Immunol. pmid:18178816
Schulman ES et al. Heterogeneity of human mast cells. 1983 J. Immunol. pmid:6194221
Holgate ST et al. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. 1984 J. Immunol. pmid:6206153
Satoh T et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. 2006 J. Immunol. pmid:16888024
Massey WA et al. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. 1991 J. Immunol. pmid:1715365
Okayama Y et al. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. 2001 J. Immunol. pmid:11254731
Patel HJ et al. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. 2003 J. Immunol. pmid:12594295
Chen Y et al. Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor. 2007 J. Immunol. pmid:17709490
Ahmed SR et al. Prostaglandin D2 regulates CD4+ memory T cell trafficking across blood vascular endothelium and primes these cells for clearance across lymphatic endothelium. 2011 J. Immunol. pmid:21715691
Tagen M et al. Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content. 2009 J. Immunol. pmid:19846869
Napimoga MH et al. Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model. 2012 J. Immunol. pmid:22706081
Nomiya R et al. CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice. 2008 J. Immunol. pmid:18390753
Pang L et al. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. 2003 J. Immunol. pmid:12517972
Schulman ES et al. Histochemical heterogeneity of dispersed human lung mast cells. 1990 J. Immunol. pmid:1692857